锦波生物：养生堂增持股份达6.24%

Group 1 - The core point of the article is that Yangshengtang Co., Ltd. plans to increase its stake in Jinbo Bio through a directed issuance, with an increase ratio of 6.24% [1] - The share change requires approval from the second extraordinary general meeting of shareholders in 2025, as well as review by the Beijing Stock Exchange and registration consent from the China Securities Regulatory Commission before implementation [1] - Jiushi Management Consulting Partnership has increased its stake in Jinbo Bio by 5% through a transfer agreement [1]